Targeting Therapy-Resistant Multiple Myeloma with a Novel Pan ALDH Inhibitor: A New Frontier in Overcoming Relapse

Project Details

StatusActive
Effective start/end date2/17/25 → 2/16/26

Funding

  • New Jersey Health Foundation, Inc. (NJHF): $50,000.00